Literature DB >> 3793206

Platelet involvement in rat paw edema induced by 2-methoxy-PAF.

P M Silva, R S Cordeiro, M A Martins, M G Henriques, B B Vargaftig.   

Abstract

PAF-acether (PAF) or 2-methoxy-PAF (2-MX) caused a dose-dependent paw edema showing a 1:25 ratio between their inflammatory activities. 2-MX caused a thrombocytopenia, whereas PAF did not alter the number of these cells. Both phospholipids induced reductions in total leukocyte count. Rat antiplatelet serum produced platelet depletion by PAF-induced paw edema was unaffected. The edema of 2-MX was significantly reduced by antiplatelet serum, under conditions where normal serum was inactive against the edema induced by PAF or 2-MX. Histopathological analysis of PAF and 2-MX-induced edema showed, in the first case, a small infiltrate of neutrophils, some lymphocytes, and several mastocytes around the vessels and, in the second, a neutrophilic infiltrate. These results suggest that PAF and 2-MX may produce edema through different mechanisms and that 2-MX causes edema in part through platelet activation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3793206     DOI: 10.1007/bf00915823

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  Platelets, acute inflammation and inflammatory mediators.

Authors:  S H Ferreira; F B Ubatuba; J R Vane
Journal:  Agents Actions       Date:  1976-02

2.  The role of platelet-activating factor in platelet aggregation.

Authors:  M Chignard; J P Le Couedic; M Tence; B B Vargaftig; J Benveniste
Journal:  Nature       Date:  1979-06-28       Impact factor: 49.962

3.  Antigen induced histamine release from platelets of rabbits producing homologous PCA antibody.

Authors:  J F Barbaro; N J Zvaifler
Journal:  Proc Soc Exp Biol Med       Date:  1966 Aug-Sep

4.  Effects of hydrocortisone on the cells in an acute inflammatory exudate.

Authors:  C E Slonecker; W C Lim
Journal:  Lab Invest       Date:  1972-07       Impact factor: 5.662

5.  Anaphylactic actions of platelet-activating factor.

Authors:  N P Stimler; C M Bloor; T E Hugli; R L Wykle; C E McCall; J T O'Flaherty
Journal:  Am J Pathol       Date:  1981-10       Impact factor: 4.307

6.  Resolution of pulmonary inflammation.

Authors:  P M Henson; G L Larsen; J E Henson; S L Newman; R A Musson; C C Leslie
Journal:  Fed Proc       Date:  1984-10

7.  Potent platelet stimulating activity of enantiomers of acetyl glyceryl ether phosphorylcholine and its methoxy analogues.

Authors:  D J Hanahan; P G Munder; K Satouchi; L McManus; R N Pinckard
Journal:  Biochem Biophys Res Commun       Date:  1981-03-16       Impact factor: 3.575

8.  Vasoactive properties of acetyl glyceryl ether phosphorylcholine and analogues.

Authors:  D M Humphrey; L M McManus; K Satouchi; D J Hanahan; R N Pinckard
Journal:  Lab Invest       Date:  1982-04       Impact factor: 5.662

9.  Effect of platelet activating factor on leukocytes. II. Enhancement of eosinophil chemotactic factor and beta-glucuronidase release.

Authors:  B M Czarneztki
Journal:  Chem Phys Lipids       Date:  1982-10       Impact factor: 3.329

10.  Blockade of the inflammatory effects of platelet-activating factor by cyclo-oxygenase inhibitors.

Authors:  B B Vargaftig; S H Ferreira
Journal:  Braz J Med Biol Res       Date:  1981-07       Impact factor: 2.590

View more
  3 in total

1.  Failure of PAF-acether to induce in vivo neutrophil migration.

Authors:  F Q Cunha; N E Heluy-Neto; A Klein; G E Souza; S H Ferreira
Journal:  Agents Actions       Date:  1988-08

2.  Differential inhibition by two hetrazepine PAF antagonists of acute inflammation in the mouse.

Authors:  M G Henriques; V B Weg; M A Martins; P M Silva; P D Fernandes; R S Cordeiro; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1990-01       Impact factor: 8.739

3.  Pharmacological modulation of Paf-induced rat pleurisy and its role in inflammation by zymosan.

Authors:  M A Martins; P M Silva; H C Faria Neto; P T Bozza; P M Dias; M C Lima; R S Cordeiro; B B Vargaftig
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.